Home Page
Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Donate Now
Access Resources

MJFF Publications
3661 - 3670 of 9148 Results
Title
Year
  • Year
  • 2024
  • 2014
  • 2017
  • 2016
  • 2022
  • 2020
  • 2022
  • 2026
  • 2015
  • 2023
  • Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    2024
    Summary Details
    OPEN
    Title: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Author(s): Beatrix Feigl, Simon J.G. Lewis, Lucy Burr, Daniel Schweitzer, Subodh Gnyawali, Dimitrios Vagenas, Drew D. Carter, Andrew J. Zele
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Vol: 69
    Issue #:
    Start Page: 102474
    End Page: 102474
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474
    Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdf
    Citation Count: 26
  • Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome
    2014
    Summary Details
    OPEN
    Title: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome
    Author(s): Haiyan Tan, Zhiping Wu, Hong Wang, Bing Bai, Yuxin Li, Xusheng Wang, Bo Zhai, Thomas G. Beach, Junmin Peng
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Vol: 15
    Issue #: 2-3
    Start Page: 500
    End Page: 507
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201400171
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4598062
    Citation Count: 68
  • Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy
    2017
    Summary Details
    OPEN
    Title: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy
    Author(s): P. Justin Rossi, Sol De Jesus, Christopher W. Hess, Daniel Martínez-Ramírez, Kelly D. Foote, Aysegul Gunduz, Michael S. Okun
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 44
    Issue #:
    Start Page: 13
    End Page: 17
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006
    Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdf
    Citation Count: 26
  • Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders
    2016
    Summary Details
    RESTRICTED
    Title: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders
    Author(s): Fanny Pineau, Emmanuel Roze, Lucette Lacomblez, Muriel Bonnet, Marie Vidailhet, Virginie Czernecki, Jean‐Christophe Corvol
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Vol: 123
    Issue #: 6
    Start Page: 573
    End Page: 581
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-016-1549-y
    Best OA location URL: https://hal.sorbonne-universite.fr/hal-01311564
    Citation Count: 18
  • Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
    2022
    Summary Details
    OPEN
    Title: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
    Author(s): Abby L. Olsen, Sabrina G. Clemens, Mel Β. Feany
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 38
    Issue #: 2
    Start Page: 244
    End Page: 255
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29283
    Best OA location URL: https://doi.org/10.1002/mds.29283
    Citation Count: 33
  • Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    2020
    Summary Details
    OPEN
    Title: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    Author(s): Tim Ahfeldt, Alban Ordureau, Christina Bell, Lily Sarrafha, Chicheng Sun, Silvia Piccinotti, Tobias Graß, Gustavo Morrone Parfitt, João A. Paulo, Fumiki Yanagawa, Takayuki Uozumi, Yasujiro Kiyota, J. Wade Harper, Lee L. Rubin
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Vol: 14
    Issue #: 1
    Start Page: 75
    End Page: 90
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005
    Best OA location URL: http://www.cell.com/article/S2213671119304448/pdf
    Citation Count: 63
  • Endolysosomal cholesterol export: More than just NPC1
    2022
    Summary Details
    OPEN
    Title: Endolysosomal cholesterol export: More than just NPC1
    Author(s): Albert Lu
    Journal Name: BioEssays
    Publisher: Wiley
    Vol: 44
    Issue #: 10
    Start Page: e2200111
    End Page: e2200111
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/bies.202200111
    Citation Count: 20
  • Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study
    2026
    Summary Details
    OPEN
    Title: Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study
    Author(s): Nikolaos Papagiannakis, Christos Koros, Athina-Maria Simitsi, Leonidas Stefanis, and The Parkinson's Progression Markers Initiative
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 41
    Issue #: 6
    Start Page: 1580
    End Page: 1585
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70236
    Best OA location URL: https://doi.org/10.1002/mds.70236
    Citation Count: 0
  • Genome‐wide variant by serum urate interaction in Parkinson's disease
    2015
    Summary Details
    RESTRICTED
    Title: Genome‐wide variant by serum urate interaction in Parkinson's disease
    Author(s): Arash Nazeri, Tina Roostaei, Shokufeh Sadaghiani, M. Mallar Chakravarty, Shirley Eberly, Anthony E. Lang, Aristotle N. Voineskos
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Vol: 78
    Issue #: 5
    Start Page: 731
    End Page: 741
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24504
    Citation Count: 12
  • Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
    2023
    Summary Details
    OPEN
    Title: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
    Author(s): Priyanka Gorijala, Muhammad Aslam, Lam‐Ha T. Dang, Laura Xicota, María Victoria Fernández, Yun Ju Sung, Kang‐Hsien Fan, Eleanor Feingold, Ezequiel Surace, Jasmeer P. Chhatwal, Christy Hom, Dominantly Inherited Alzheimer Network (DIAN), the Alzheimer's Disease Neuroimaging Initiative (ADNI), Sigan L. Hartley, Jason Hassenstab, Richard J. Perrin, Mark Mapstone, Shahid Zaman, Beau M. Ances, M. Ilyas Kamboh, Joseph H. Lee, Carlos Cruchaga
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 20
    Issue #: 2
    Start Page: 1038
    End Page: 1049
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13506
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13506
    Citation Count: 13

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Give Today About Our Campaign
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.